Othon Gervasio

Othon Gervasio Email and Phone Number

Chief Medical Officer @ Clarity Pharmaceuticals
australia
Othon Gervasio's Location
Greater Sydney Area, Australia
About Othon Gervasio

Strategic, dynamic, patient and customer-centric Medical Director, with a passion for connecting the business overarching strategy with both medical and commercial goals. With over 20 years' academic and Medical Affairs experience, I have excelled in managing large teams, overseeing a high number of therapeutic areas and across countries. I have considerable experience in data analytics in Medical Affairs (clinical and non-clinical data), digital strategy and leveraging Real World Evidence to improve the quality use of medicines and to support business goals. I enjoy building and nurturing high performing teams and providing the tools and environment to help them succeed.

Othon Gervasio's Current Company Details
Clarity Pharmaceuticals

Clarity Pharmaceuticals

View
Chief Medical Officer
australia
Employees:
20
Othon Gervasio Work Experience Details
  • Clarity Pharmaceuticals
    Chief Medical Officer
    Clarity Pharmaceuticals Jul 2024 - Present
    Australia
  • Clarity Pharmaceuticals
    Senior Medical Director
    Clarity Pharmaceuticals May 2023 - Jul 2024
    Australia
  • Novartis
    Medical Director
    Novartis Jun 2018 - Sep 2022
    Australia
    - Member of the Country Executive Oncology Leadership team, designing the vision, developing 5-year strategy, and establishing culture- Leader of the Solid Tumours, Haematology and Cell & Gene Medical Affairs teams, including Investigator Initiated Trials, Phase IV studies/registries, Compassionate Programs, with oversight of over 15 disease states- Strength-based coaching and development, fostering a culture of empowerment, engagement, psychological safety, measured risk-taking and integrity - Finance and budget responsibilities, resource allocation, recruitment, retention and development of talents, RWE studies supporting regulatory submissions, executive approval of SOPs, grants review/approval, protocol approvals in ANZ, APAC, Middle East and Africa- Data and digital strategy oversight, insights generation, omnichannel, leading to the optimisation of systems, processes and customer experience in medical affairs- Oversight of Statistical Analysis Plans (inferential/descriptive statistics) and database implementations (validation/deployment) for analysis of clinical information- Launch of several brands, including Kymriah (tisagenlecleucel): integral member of the team who led the registration (TGA) and reimbursement (MSAC) of the first CAR-T and cell therapies-based treatment in Australia- Regional Award for leading and implementing “Ways of Working”: integration of new ways of working into workplace behaviours; driving an open, empowering, transparent, and inspiring culture throughout the organisation- Early Access to Medicines: implementation of initiatives to streamline processes, driving savings and increasing the speed/number of request evaluation- “Courage Award”: partnering with several stakeholders to support registration and reimbursement submissions. Successful engagement with Health Authorities leading to positive outcomes for patients (equitable and sustainable access to medicines)
  • Novartis
    Acting Medical Director
    Novartis Jul 2017 - May 2018
    Sydney, Australia
  • Novartis
    Head Of Medical, Haematology
    Novartis Nov 2012 - Jun 2017
    Sydney, Australia
    - Leading a team of 5 associates, Senior Medical Advisors and Senior Medical Scientific Liaisons- Supervision of the product development team for compounds in development (in preparation for product launch)- Support to the development of registration and reimbursement dossiers- Publication of two national consensus statements on Meylofibrosis, coinciding with the launch of Jakavi in Australia- Oversight of the publication of national guidelines on chronic myeloid leukaemia- “Courage Award”: for partnering with several stakeholders to support registration (TGA) and reimbursement (PBS) submissions- “Competitive intelligence” Award: translating science into marketing strategies for commercial use and improvement of patient outcomes- Two “On the spot Awards”: medical education weekend meetings – excellence in delivery of medical education- Two “On the spot awards”: Coach and Lead, and Excellence in organizing an Investigator Meeting to improve recruitment of patients to clinical trials
  • Novartis
    Acting Medical Director
    Novartis Aug 2016 - Oct 2016
    Sydney, Australia
  • Novartis
    Senior Medical Advisor
    Novartis Mar 2012 - Nov 2012
    - Medical education initiatives attended by several hundred medical experts, including international speakers and patient groups- Digital initiatives to deliver live and on-demand medical education across Australia and overseas, creating opportunities for exchange pre/during/post-events - Local support and management of pre-clinical/translational research, and phase I-IV clinical trials (global, local-sponsored, investigator-initiated, including Real World Evidence studies)- Planning and implementation of numerous local activities (e.g. national educational meetings, advisory boards, clinical studies, national treatment guidelines)- Development of concepts, protocols, and protocol amendments for clinical trials- Training and support of Product Specialists (including, but not limited to, training on utilizing new promotional materials, field visits and coaching, and objection handling workshops)- Collaboration with the marketing team to produce and implement promotional materials, including copy clearance- Publication of national treatment guidelines on the management of iron overload, and how to optimally treat patients with iron chelators- Support to the development of registration and reimbursement dossiers- Nomination for “Team award” Regional award. Medical education weekend meeting - Annual Award “External focus”. First prize. Nominations across both Oncology and General Medicines- 2011 Nomination for “Best teamwork”, Quarterly Award. For several activities developed with the marketing team
  • Novartis
    Medical Advisor
    Novartis Apr 2009 - Mar 2012
  • Sydney University
    Postdoctoral Researcher 1/2
    Sydney University May 2006 - Apr 2009
  • University Of Sydney
    Postdoctoral Researcher 2/2
    University Of Sydney Feb 2003 - Apr 2006
  • Eustaquio Araujo Ortodontia
    Orthodontic And General Dental Practice
    Eustaquio Araujo Ortodontia 1998 - 2000

Othon Gervasio Education Details

Frequently Asked Questions about Othon Gervasio

What company does Othon Gervasio work for?

Othon Gervasio works for Clarity Pharmaceuticals

What is Othon Gervasio's role at the current company?

Othon Gervasio's current role is Chief Medical Officer.

What schools did Othon Gervasio attend?

Othon Gervasio attended Universidade Federal De Minas Gerais, University Of Melbourne, Universidade Federal De Minas Gerais, Universidade Federal De Minas Gerais.

Who are Othon Gervasio's colleagues?

Othon Gervasio's colleagues are Ashley Kinoshita, Lisa Coy, Gabriel Gutfilen Schlesinger, Lachlan Mcinnes, Matt Harris, Albert Tondreau, Tamlyn Ji-Schmidt.

Not the Othon Gervasio you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.